Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Evidence-Based Management of Sickle Cell Disease: Expert Panel Report, 2014

About this resource:

HHS Non-systematic Review

Source: National Heart, Lung, and Blood Institute

Last Reviewed: September 2014

Workgroups: Blood Disorders and Blood Safety Workgroup

This report provides recommendations to help primary care providers and other clinicians, nurses, and staff make decisions about the treatment and care of people with sickle cell disease. It includes guidelines related to:

  • Routine health maintenance
  • Recognition and treatment of common complications
  • Prescribing  and monitoring hydroxyurea and blood transfusion therapy
Read more about this resource

Objectives related to this resource (1)

Increase the proportion of people with sickle cell disease on Medicare who received disease-modifying therapies — BDBS‑02
Baseline only

Suggested Citation

1.

National Institutes of Health, National Heart, Lung, and Blood Institute. (2014). Evidence-based management of sickle cell disease: expert panel report, 2014. Retrieved from https://www.nhlbi.nih.gov/health-topics/evidence-based-management-sickle-cell-disease